|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM249237814 |
003 |
DE-627 |
005 |
20231224153134.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2015 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1080/08997659.2014.993484
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0830.xml
|
035 |
|
|
|a (DE-627)NLM249237814
|
035 |
|
|
|a (NLM)25997556
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Hu, Kun
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Chitosan Influences the Expression of P-gp and Metabolism of Norfloxacin in Grass Carp
|
264 |
|
1 |
|c 2015
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 18.09.2015
|
500 |
|
|
|a Date Revised 30.09.2020
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a The aim of this study was to investigate the relationship between the administration of chitosan (CTS), expression of permeability glycoprotein (P-gp), and the metabolism of norfloxacin (NOR) in Grass Carp Ctenopharyngodon idella. Fish were administrated with a single dose of either NOR, CTS, 1:5 NOR-CTS or 1:10 NOR-CTS. The P-gp expression was analyzed by immunohistochemistry and real time-PCR. The concentration of NOR was determined using HPLC. The mRNA and protein expression of P-gp in the fish intestine was significantly enhanced following a single dosage of 40 mg/kg NOR, and peak expression occurred at 3 h after drug administration (P < 0.05). A single dosage of both 1:5 NOR-CTS and 1:10 NOR-CTS reduced the intestinal P-gp expression to levels significantly lower than that from NOR alone (P < 0.05), but significantly higher than that from the control (P < 0.05). Interestingly, CTS alone also led to a slight decrease in P-gp expression. In addition, pharmacokinetic assays revealed a marked increase in area under the curve (AUC) of NOR with 1:5 and 1:10 NOR-CTS, by approximately 1.5-fold and threefold, respectively. Finally, the relative bioavailability of NOR after a single oral dosage of 1:5 and 1:10 NOR-CTS was enhanced to 148.02% and 304.98%, respectively. In this study, we demonstrated that the transmembrane glycoprotein P-gp regulates NOR metabolism in the intestine of Grass Carp, suggesting that NOR may be a direct substrate of P-gp. More importantly, we showed that CTS can inhibit P-gp expression in a dose-dependent manner and improve the relative bioavailability of NOR in this species
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a ATP Binding Cassette Transporter, Subfamily B, Member 1
|2 NLM
|
650 |
|
7 |
|a Anti-Bacterial Agents
|2 NLM
|
650 |
|
7 |
|a RNA, Messenger
|2 NLM
|
650 |
|
7 |
|a Chitosan
|2 NLM
|
650 |
|
7 |
|a 9012-76-4
|2 NLM
|
650 |
|
7 |
|a Norfloxacin
|2 NLM
|
650 |
|
7 |
|a N0F8P22L1P
|2 NLM
|
700 |
1 |
|
|a Xie, Xinyan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhao, Yi-Ni
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Yi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ruan, Jiming
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Hao-Ran
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Jin, Tianyi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yang, Xian-Le
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Journal of aquatic animal health
|d 1998
|g 27(2015), 2 vom: 22. Juni, Seite 104-11
|w (DE-627)NLM098202006
|x 1548-8667
|7 nnns
|
773 |
1 |
8 |
|g volume:27
|g year:2015
|g number:2
|g day:22
|g month:06
|g pages:104-11
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1080/08997659.2014.993484
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 27
|j 2015
|e 2
|b 22
|c 06
|h 104-11
|